Qurient Co., Ltd.
Clinical-stage biopharma developing drugs for oncology, cGvHD, and tuberculosis.
115180 | KO
Overview
Corporate Details
- ISIN(s):
- KR7115180002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 242, C동 8층, 성남시
- Website:
- http://www.qurient.com/
Description
Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-06 00:00 |
투자판단관련주요경영사항(면역항암제 Q702와 키트루다주(펨브롤리주맙) 병용투여에 관한 한국 식품의약품안전처(MFDS) 임상 제1B/2상 시험계…
|
Korean | 10.7 KB | ||
| 2022-09-06 00:00 |
[기재정정]투자판단관련주요경영사항(면역항암제 Q702와 Pembrolizumab(키투르다) 병용 임상1B/2상 시험계획 제출)
|
Korean | 13.2 KB | ||
| 2022-08-29 00:00 |
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2022-08-29 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2022-08-17 00:00 |
기타시장안내(개선기간 종료에 따른 상장폐지여부 결정 안내)
|
Korean | 3.6 KB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 820.1 KB | ||
| 2022-07-15 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 14.2 KB | ||
| 2022-07-08 00:00 |
투자판단관련주요경영사항(면역항암제 Q702와 Pembrolizumab(키투르다) 병용투여에 관한 한국 식품의약품안전처(MFDS) 임상 제1B/…
|
Korean | 10.3 KB | ||
| 2022-06-13 00:00 |
유상증자결정(종속회사의주요경영사항)
|
Korean | 22.3 KB | ||
| 2022-05-30 00:00 |
[기재정정]투자판단관련주요경영사항(항암치료제 Q901 미국 임상 1/2상 시험 계획(IND) 승인)
|
Korean | 13.0 KB | ||
| 2022-05-16 00:00 |
분기보고서 (2022.03)
|
Korean | 823.5 KB | ||
| 2022-04-04 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 58.6 KB | ||
| 2022-04-04 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.3 KB | ||
| 2022-03-30 00:00 |
정기주주총회결과
|
Korean | 23.7 KB | ||
| 2022-03-22 00:00 |
사업보고서 (2021.12)
|
Korean | 380.3 KB |
Automate Your Workflow. Get a real-time feed of all Qurient Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Qurient Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Qurient Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
